Orbimed Advisors LLC Agios Pharmaceuticals, Inc. Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$19.97 - $24.53 $898,650 - $1.1 Million
45,000 New
45,000 $1 Million
Q1 2021

May 17, 2021
SELL
$44.23 - $57.5 $97.6 Million - $127 Million
-2,207,321 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$33.87 - $55.93 $16.2 Million - $26.8 Million
478,900 Added 27.71%
2,207,321 $77.3 Million
Q2 2020

Aug 14, 2020
BUY
$34.45 - $53.48 $2.61 Million - $4.05 Million
75,725 Added 4.58%
1,728,421 $92.4 Million
Q1 2020

May 15, 2020
BUY
$31.52 - $53.81 $52.1 Million - $88.9 Million
1,652,696 New
1,652,696 $58.6 Million

Others Institutions Holding AGIO

# of Institutions
232
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.05B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email